Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.21/3072
Título: eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development
Autor: Malta-Vacas, Joana
Chauvin, Celine
Gonçalves, Lucília
Nazaré, Antónia
Carvalho, Carlos
Monteiro, Carolino
Bagrel, Denyse
Jean-Jean, Olivier
Brito, Miguel
Palavras-chave: Breast neoplasms
Case-control studies
Cell line, Tumor
Gene frequency
Genetic predisposition to disease
Odds ratio
Peptide termination factors
Polymorphism, Genetic
RNA interference
Risk assessment
Risk factor
Data: Jun-2009
Editora: Spandidos Publications
Citação: Malta-Vacas J, Chauvin C, Gonçalves L, Nazaré A, Carvalho C, Brito M, et al. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Oncol Rep. 2009;21(6):1551-8.
Resumo: It is now widely recognized that translation factors are involved in cancer development and that components of the translation machinery that are deregulated in cancer cells may become targets for cancer therapy. The eukaryotic Release Factor 3 (eRF3) is a GTPase that associates with eRF1 in a complex that mediates translation termination. eRF3a/GSPT1 first exon contains a (GGC)n expansion coding for proteins with different N-terminal extremities. Herein we show that the longer allele (12-GGC) is present in 5.1% (7/137) of the breast cancer patients analysed and is absent in the control population (0/135), corresponding to an increased risk for cancer development, as revealed by Odds Ratio analysis. mRNA quantification suggests that patients with the 12-GGC allele overexpress eRF3a/GSPT1 in tumor tissues relative to the normal adjacent tissues. However, using an in vivo assay for translation termination in HEK293 cells, we do not detect any difference in the activity of the eRF3a proteins encoded by the various eRF3a/GSPT1 alleles. Although the connection between the presence of eRF3a/GSPT1 12-GGC allele and tumorigenesis is still unknown, our data suggest that the presence of the 12-GGC allele provides a potential novel risk marker for various types of cancer.
Peer review: yes
URI: http://hdl.handle.net/10400.21/3072
ISSN: 1791-2431
Versão do Editor: http://www.spandidos-publications.com/or/21/6/1551
Aparece nas colecções:ESTeSL - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
eRF3a GSPT1 12-GGC allele increases the susceptibility.pdf250,63 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.